CCL2 and infection: Interestingly, we found differences in the expression of several immune-barrier molecules (filaggrin, MIP-1α/CCL3, MIP-1β/CCL4 and MCP-1) in NPA supernatants of virus-negative controls compared to negative pre-infection samples of RVI neonates.